|
|
| Research article summary (published 30 Oct 2009): |
Androgen receptor as a potential sign of prostate cancer metastasis.
Full Abstract
BACKGROUND: Androgen receptor (AR) expression and its modulation through the carcinogenesis process have been investigated in several studies with conflicting results. MATERIALS AND METHODS: In situ hybridization and immunocytochemistry were used to examine AR expression in prostatic needle core biopsies of benign, high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma. RESULTS: A significant increase in AR mRNA levels was found in the cancerous prostatic cells when compared with the benign tissue biopsies. AR abundance in HGPIN was found to be almost half-way between that observed in benign and in cancerous tissue. In the benign prostatic epithelium, the immunocytochemistry data show that AR is exclusively expressed in the nuclei of epithelial cells. However, in 72% of examined cancer biopsies, AR was expressed in both the cytoplasm and nuclei. After examination of medical records of 100 patients diagnosed with prostate cancer, it was found that the AR was expressed in both cellular compartments of cancer cells in 81% of cases when cancer was found to have metastasized outside the prostate. In contrast, when the cancer was organ-confined, AR was localized in both the nuclei and cytoplasm in only 66% of cases. Moreover, when the AR was expressed in the cytoplasm of cancerous cells, consecutive serial sections immunostained with the mitochondrial marker suggest that AR is localized in the mitochondria. CONCLUSIONS: AR mRNA expression is significantly higher in prostate cancer when compared to benign prostatic tissue.
Author information
Author/s: Lévesque, Marie-Hélène (MH); El-Alfy, Mohamed (M); Cusan, Leonello (L); Labrie, Fernand (F);
Affiliation: Laval University Hospital Research Center (CRCHUL) and Laval University, Quebec City, Quebec, Canada.
Journal and publication information
Publication Type: Journal Article
Journal: The Prostate (Prostate), published in United States. (Language: eng)
Reference: 2009-Nov; vol 69 (issue 15) : pp 1704-11
Dates: Created 2009/09/28; Completed 2009/10/15;
PMID: 19670238, status: MEDLINE (last retrieval date: 10/15/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
30 Mar 1999 - SEL1L expression in prostatic intraepithelial neoplasia and adenocarcinoma: an immunohistochemical study.
30 Mar 2006 - Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status.
29 Jun 2004 - Progression-linked overexpression of c-Met in prostatic intraepithelial neoplasia and latent as well as clinical prostate cancers.
29 Jun 1999 - Foamy gland microcarcinoma in needle prostatic biopsy.
5 Jul 2008 - Loss of 14-3-3sigma in prostate cancer and its precursors.
29 Apr 2004 - Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
30 Oct 2004 - Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma.
30 Dec 2005 - Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
30 May 2005 - The utility of Ki-67 expression in the differential diagnosis of prostatic intraepithelial neoplasia and ductal adenocarcinoma.
29 Apr 2005
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.